Viewing nowEve Bone Tablet 150mg (Ibandronic Acid Sodium Hydrate)
Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

MFDS item code 201308598 · Approved 2013.07.31 · Insurance code 648602510
Treatment of osteoporosis in postmenopausal women
In postmenopausal women, osteoporosis can weaken bone strength and increase the risk of fractures. This medication helps strengthen bones and increase bone density, reducing fracture risk. Therefore, it is used for the treatment of osteoporosis in postmenopausal women.
Take 1 tablet once monthly, regularly on the same morning each month, with plenty of water at least 1 hour before consuming food, beverages (other than water), or other oral medicines or dietary supplements (including calcium): - This medicine should be swallowed with plenty of water (180-240ml) while standing or sitting upright, and you should not lie down for 60 minutes after taking it. - Take this medicine with plain water, as mineral water may reduce its absorption. - Do not chew or suck the tablet, to avoid esophageal ulcers. If a patient forgets to take the medicine on the scheduled day: - If 8 days or more remain until the next scheduled dose, take 1 tablet the morning after realizing that a dose was missed, then take 1 tablet monthly on the originally scheduled day thereafter. - If 7 days or fewer remain until the next scheduled dose, take 1 tablet on the next scheduled day, then continue taking 1 tablet monthly on the originally scheduled day thereafter. - Do not take 2 tablets in the same week. Patients with inadequate dietary intake should supplement calcium or vitamin D, etc. Patients with hepatic impairment No dosage adjustment is necessary. Patients with renal impairment No dosage adjustment is necessary in patients with mild or moderate renal impairment with creatinine clearance of 30mL/min or greater. There is insufficient clinical experience in patients with creatinine clearance less than 30mL/min; therefore, use of this medicine is not recommended. Elderly No dosage adjustment is necessary.
Efficacy and safety in children 18 years of age or younger have not been studied.
This medication should not be used in certain patients. For example, it should not be taken by individuals allergic to this medication or its components, patients with untreated hypocalcemia, individuals who cannot sit or stand upright for more than 60 minutes, or those with esophageal dysfunction that may impair swallowing. Additionally, since this medication contains lactose, individuals with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should also avoid it. Patients with severely impaired renal function should use this medication with caution. Taking this medication may cause various side effects such as dyspepsia, nausea, abdominal pain, diarrhea, headaches, myalgia, arthralgia, rash, etc. Notably, symptoms similar to influenza, such as arthralgia, myalgia, fever, chills, and fatigue may occur after the first dose, but they are usually mild and transient. Moreover, esophageal issues related to esophagitis, esophageal ulcers, and esophageal strictures may arise, so if there is discomfort swallowing or chest pain when taking the medication, consult a physician immediately. This medication can irritate the gastric mucosa, so patients with gastrointestinal diseases should be cautious, and it should also be used with care when taking non-steroidal anti-inflammatory drugs. Rare incidents of osteonecrosis of the jaw have been reported, so it is advisable to check oral health before dental treatment and avoid excessive dental treatment while on this medication. Rarely, osteonecrosis of the external auditory canal or ocular inflammation may occur, so any abnormal symptoms in the ears or eyes should be reported to healthcare professionals. Prolonged use of this medication may lead to atypical fractures of the femur or other bones, so if pain occurs in the thigh or groin, medical attention should be sought immediately. While taking this medication, food, calcium, antacids, etc., may reduce the absorption of the medication, making it essential not to take any other food or medications for at least one hour after taking this medication. It is safer not to use this medication during pregnancy or breastfeeding, and safety for children under 18 has not been confirmed. Lastly, an overdose of this medication may cause gastrointestinal disorders or hypocalcemia, so it is crucial to adhere to the prescribed usage and dosage, and after taking the medication, do not lie down for a certain period.
Dyspepsia, nausea, abdominal pain, diarrhea, bloating, gastroesophageal reflux disease, headache, influenza-like illness, fatigue, myalgia, arthralgia, rash, gastritis, esophagitis, muscle cramps, musculoskeletal pain, musculoskeletal stiffness, dysphagia, vomiting, dizziness, low back pain, duodenitis, hypersensitivity reactions, angioedema, facial swelling, urticaria, uveitis, scleritis, jaw and external auditory canal osteonecrosis, anaphylactic reaction, shock, asthma exacerbation, Stevens-Johnson syndrome, erythema multiforme, vesicular dermatitis, atypical subtrochanteric and femoral neck fractures, atypical fractures of the ilium, abnormal sensation in the eyes, weakness, pruritus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to keep the storage temperature between 1 degree and 30 degrees Celsius to maintain the effectiveness of the medication.
White to almost white oblong film-coated tablets
1 tablet/PTP packaging
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIbandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ibandronate Sodium Monohydrate 3.375mg
Solution · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.